News
Biotech firm attracts $29 million in 2nd funding round. Spaltudaq
March 17, 2007 /
Seattle-based Spaltudaq http://www.spaltudaq.com/ started out as one man in a lab with an idea for fighting cancer.
Now it’s scored $29 million in its second round of venture-capital funding, a shot in the arm that should carry the biotech company into its first round of clinical trials.
By Kirsten Orsini-Meinhard
Seattle Times business reporter
Full Story: http://seattletimes.nwsource.com/html/businesstechnology/2003622556_spaltudaq17.html
MATR Supporters (view all)
Posted in: Washington State Business
Sorry, we couldn't find any posts. Please try a different search.